#novo nordisk

All articles tagged with "novo nordisk"

Novo Nordisk Says 1 Million Obesity Patients Are Already Taking Its Wegovy Pill

Novo Nordisk used its first-quarter update to highlight early uptake for its Wegovy pill as it navigates pricing pressure, payer dynamics, and fresh competition from Eli Lilly.

Key Takeaways

Novo Nordisk said one million obesity patients are already taking its Wegovy pill.
The company reported 2.3 billion Danish kroner in pill sales, according to the supplied source text.

DT Editorial Team·May 7, 2026·via endpoints.news

Novo Nordisk Faces a Double Leadership Shift as a GLP-1 Pioneer Retires and an Obesity Executive Departs

Novo Nordisk is navigating two departures at once, including the retirement of GLP-1 pioneer Lotte Bjerre Knudsen and the loss of an obesity leader to Boehringer Ingelheim.

Key Takeaways

Novo Nordisk is facing two departures tied to its GLP-1 and obesity leadership.
Lotte Bjerre Knudsen is described in the source as a decorated GLP-1 pioneer.

DT Editorial Team·Apr 10, 2026·via endpoints.news

Novo Nordisk and Hims Strike Deal That Could End Compounded GLP-1s

Novo Nordisk and Hims & Hers have ended their legal battle with a partnership that could reshape the booming compounded GLP-1 drug market and limit cheaper alternatives.

Key Takeaways

Novo Nordisk and Hims settle legal dispute with commercial partnership
Hims will shift from compounded semaglutide to branded Novo products

DT Editorial Team·Mar 10, 2026·4 min read·via gizmodo.com

Novo Nordisk Partners With MIT-Backed Startup to Develop Oral Obesity Drugs

Novo Nordisk has struck a deal with Vivtex, a biotech co-founded by MIT professor Robert Langer, to develop oral versions of obesity and diabetes treatments. The partnership could eliminate the need for weekly injections that have defined the GLP-1 drug revolution.

DT Editorial Team·Feb 25, 2026·4 min read·via statnews.com